• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天门冬氨酸氨基转移酶(AST)与丙氨酸氨基转移酶(ALT)比值与急性缺血性脑卒中患者出血性转化风险的关系。

AST to ALT ratio and risk of hemorrhagic transformation in patients with acute ischemic stroke.

机构信息

Department of Neurology, West China Hospital, Sichuan University , Sichuan, China.

West China School of Medicine, Sichuan University , Sichuan, China.

出版信息

Neurol Res. 2020 Nov;42(11):980-986. doi: 10.1080/01616412.2020.1796403. Epub 2020 Jul 22.

DOI:10.1080/01616412.2020.1796403
PMID:32697140
Abstract

BACKGROUND

Hemorrhagic transformation (HT) is a common complication of ischemic stroke. We performed this study to determine whether aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio (AAR) was related to HT, as well as compare the predictive values of AAR, ALT and AST for HT in patients with ischemic stroke.

METHODS

We included ischemic stroke patients within 7 days of onset. HT was identified by a follow-up imaging examination. Univariate and multivariate logistic regression models were performed to assess the association between AAR and HT. Net reclassification index (NRI) was calculated to assess the ability of AAR, AST and ALT to reclassify risks of HT.

RESULTS

A total of 2042 (median age: 69 years; 63.2% males) patients were included in this study, of whom 232 (11.4%) were identified as HT. The receiver-operating characteristic curve analysis showed that the optimal cut-off value for AAR to predict HT was 1.22. Higher AAR (≥1.22) was an independent predictor associated with HT (OR 1.44, 95%CI 1.06-1.97, = 0.02) after adjusting for covariates. A U-shaped dose-effect relationship was found between AAR level and HT in logistic regression model with restricted cubic splines. In addition, adding AAR to a model containing conventional risk factors significantly improved predictive power for HT (NRI: 15.4%, = 0.027), but not for ALT (NRI: 10.3%, = 0.141) or AST (NRI: 8.3%, = 0.237).

CONCLUSIONS

Higher AAR was associated with an increased risk of HT after ischemic stroke. In addition, AAR might be a better biomarker for predicting HT than ALT or AST.

摘要

背景

出血转化(HT)是缺血性脑卒中的常见并发症。我们进行这项研究旨在确定天冬氨酸氨基转移酶(AST)与丙氨酸氨基转移酶(ALT)比值(AAR)是否与 HT 相关,并比较 AAR、ALT 和 AST 对缺血性脑卒中患者 HT 的预测价值。

方法

我们纳入了发病 7 天内的缺血性脑卒中患者。通过随访影像学检查确定 HT。采用单因素和多因素逻辑回归模型评估 AAR 与 HT 之间的关系。计算净重新分类指数(NRI)以评估 AAR、AST 和 ALT 重新分类 HT 风险的能力。

结果

共纳入 2042 例(中位年龄:69 岁;63.2%为男性)患者,其中 232 例(11.4%)发生 HT。受试者工作特征曲线分析显示,AAR 预测 HT 的最佳截断值为 1.22。在校正协变量后,较高的 AAR(≥1.22)是与 HT 相关的独立预测因素(OR 1.44,95%CI 1.06-1.97, = 0.02)。在受限立方样条的逻辑回归模型中,AAR 水平与 HT 之间呈 U 形剂量-效应关系。此外,在包含常规危险因素的模型中添加 AAR 可显著提高 HT 的预测能力(NRI:15.4%, = 0.027),但对 ALT(NRI:10.3%, = 0.141)或 AST(NRI:8.3%, = 0.237)无影响。

结论

较高的 AAR 与缺血性脑卒中后 HT 的风险增加相关。此外,AAR 可能是预测 HT 比 ALT 或 AST 更好的生物标志物。

相似文献

1
AST to ALT ratio and risk of hemorrhagic transformation in patients with acute ischemic stroke.天门冬氨酸氨基转移酶(AST)与丙氨酸氨基转移酶(ALT)比值与急性缺血性脑卒中患者出血性转化风险的关系。
Neurol Res. 2020 Nov;42(11):980-986. doi: 10.1080/01616412.2020.1796403. Epub 2020 Jul 22.
2
Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke.评价 De Ritis(AST/ALT)、ALP/ALT 和 AST/ALP 比值在急性缺血性脑卒中患者中的预后因素。
BMC Neurol. 2022 Dec 3;22(1):450. doi: 10.1186/s12883-022-02989-4.
3
Prognostic Value of ALT, AST, and AAR in Hepatocellular Carcinoma with B-Type Hepatitis-Associated Cirrhosis after Radical Hepatectomy.谷丙转氨酶、谷草转氨酶和天冬氨酸氨基转移酶比值在根治性肝切除术后乙型肝炎相关性肝硬化肝细胞癌中的预后价值
Clin Lab. 2018 Oct 1;64(10):1739-1747. doi: 10.7754/Clin.Lab.2018.180532.
4
The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.谷草转氨酶/谷丙转氨酶(德瑞蒂斯)比值:外周动脉闭塞性疾病患者严重肢体缺血的一种新型标志物。
Medicine (Baltimore). 2016 Jun;95(24):e3843. doi: 10.1097/MD.0000000000003843.
5
Loss of Life Expectancy by 10 Years or More From Elevated Aspartate Aminotransferase: Finding Aspartate Aminotransferase a Better Mortality Predictor for All-Cause and Liver-Related than Alanine Aminotransferase.因天门冬氨酸氨基转移酶升高而损失 10 年或更长预期寿命:天门冬氨酸氨基转移酶比丙氨酸氨基转移酶更能预测全因和肝脏相关死亡率。
Am J Gastroenterol. 2019 Sep;114(9):1478-1487. doi: 10.14309/ajg.0000000000000332.
6
A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of postoperative acute kidney injury in patients with hepatocellular carcinoma.回顾性初步研究旨在探讨天门冬氨酸氨基转移酶/丙氨酸氨基转移酶比值对肝癌患者术后急性肾损伤的预测价值。
Ann Clin Biochem. 2019 May;56(3):357-366. doi: 10.1177/0004563218817797. Epub 2019 Feb 27.
7
De Ritis ratio (AST/ALT) as an independent predictor of poor outcome in patients with acute ischemic stroke.德瑞蒂斯比值(谷草转氨酶/谷丙转氨酶)作为急性缺血性脑卒中患者预后不良的独立预测指标。
Neuropsychiatr Dis Treat. 2017 Jun 15;13:1551-1557. doi: 10.2147/NDT.S139316. eCollection 2017.
8
Prevalence and associated metabolic factors of fatty liver disease in the elderly.老年人脂肪肝的患病率及相关代谢因素。
Exp Gerontol. 2013 Aug;48(8):705-9. doi: 10.1016/j.exger.2013.05.059. Epub 2013 May 27.
9
Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study.术前天门冬氨酸氨基转移酶/丙氨酸氨基转移酶比值评估在接受细胞减灭性肾切除术的转移性肾细胞癌患者中的独立预测生物标志物:一项倾向评分匹配研究。
Clin Genitourin Cancer. 2017 Oct;15(5):598-604. doi: 10.1016/j.clgc.2017.04.011. Epub 2017 Apr 20.
10
Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure.天门冬氨酸氨基转移酶与丙氨酸氨基转移酶比值与老年心力衰竭患者的虚弱和死亡率相关。
Sci Rep. 2021 Jun 7;11(1):11957. doi: 10.1038/s41598-021-91368-z.

引用本文的文献

1
Association of AST/ALT ratio with 90-day outcomes in patients with acute exacerbation of chronic liver disease: a prospective multicenter cohort study in China.慢性肝病急性加重患者谷草转氨酶/谷丙转氨酶比值与90天预后的关联:一项中国前瞻性多中心队列研究
Front Med (Lausanne). 2024 Mar 21;11:1307901. doi: 10.3389/fmed.2024.1307901. eCollection 2024.
2
Association of AST/ALT (De Ritis) ratio with sarcopenia in a Chinese population of community-dwelling elderly.中国社区居住老年人中谷草转氨酶/谷丙转氨酶(德瑞蒂斯)比值与肌肉减少症的关联
Heliyon. 2023 Sep 28;9(10):e20427. doi: 10.1016/j.heliyon.2023.e20427. eCollection 2023 Oct.
3
Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke.
评价 De Ritis(AST/ALT)、ALP/ALT 和 AST/ALP 比值在急性缺血性脑卒中患者中的预后因素。
BMC Neurol. 2022 Dec 3;22(1):450. doi: 10.1186/s12883-022-02989-4.
4
Prediction of Hemorrhagic Transformation After Ischemic Stroke: Development and Validation Study of a Novel Multi-biomarker Model.缺血性卒中后出血性转化的预测:一种新型多生物标志物模型的开发与验证研究
Front Aging Neurosci. 2021 May 28;13:667934. doi: 10.3389/fnagi.2021.667934. eCollection 2021.